查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1922853

日本醫療低溫運輸物流市場規模、佔有率、趨勢及預測（按產品、細分市場及地區分類，2026-2034年）

Japan Healthcare Cold Chain Logistics Market Size, Share, Trends and Forecast by Product, Segment, and Region, 2026-2034
出版日期: | 出版商: IMARC | 英文 117 Pages | 商品交期: 5-7個工作天內

價格
簡介目錄

日本醫療低溫運輸物流市場規模在2025年達到11.042億美元。 IMARC Group預測，到2034年，該市場規模將達到15.01億美元，2026年至2034年的複合年成長率（CAGR）為3.47% 。成長要素包括：對溫控生物製藥產品的需求不斷成長、冷藏保管基礎設施的改進以及日益嚴格的監管標準要求。此外，疫苗和生物製藥的擴大以及物聯網（IoT）和無線射頻識別（RFID）等先進技術在即時追蹤方面的應用，也顯著促進了市場成長。

日本醫療低溫運輸物流市場的發展趨勢：

生物製藥和個人化醫療的擴張

受生物製藥和個人化醫療需求不斷成長的推動，日本醫療低溫運輸物流行業正經歷強勁成長。單株抗體和mRNA疫苗等生物製藥需要嚴格的溫度控制才能維持其療效。截至2024年，包括日本通運和近鐵通運在內的主要物流公司已將其生物製藥低溫運輸運力從2020年的18%提升至30%。日本人口老化加劇，65歲及以上人口佔比超過30%，進一步推動了先進治療方法的需求。此外，日本政府的各項舉措，例如《2024年生命科學藍圖》以及2兆日圓的醫療數位化投資，正在加強國內生物製藥和個人化醫療的發展。據日本厚生勞動省稱，到 2023 年，全球生物製藥銷售額預計將佔日本藥品市場總額的 38% 以上，這凸顯了對可靠的低溫運輸物流以支持溫控醫療產品分銷的日益成長的需求。

低溫運輸物流的技術進步

科技創新正在改變日本的醫療低溫運輸物流，提升營運效率並保障溫度敏感型醫療產品的品質。物聯網 (IoT) 設備的整合實現了運輸和儲存過程中溫度和濕度的即時監控，從而提高了營運效率。區塊鏈技術也因其能夠提供防篡改、透明的記錄而備受關注，確保符合嚴格的監管標準，並增強相關人員的信任。例如，截至 2025 年 4 月，日本 62% 的醫院強制要求對生物製藥進行即時溫度追蹤，高於 2021 年的 45%。此外，人工智慧 (AI) 和預測分析技術正被用於預測供應鏈中潛在的中斷，從而實現風險的預先規避。這些進步對於維持敏感型醫療產品的有效性至關重要，並正在推動日本低溫運輸物流市場的成長。

本報告解答的關鍵問題

  • 日本醫療低溫運輸物流市場目前表現如何？未來幾年又將如何發展？
  • 日本醫療低溫運輸物流市場按產品分類的市場組成為何？
  • 日本醫療低溫運輸物流市場按細分市場分類的組成是怎樣的？
  • 日本醫療低溫運輸物流市場價值鏈的不同階段有哪些？
  • 日本醫療低溫運輸物流的關鍵促進因素與挑戰是什麼？
  • 日本醫療低溫運輸物流市場的結構是怎麼樣的？主要參與者有哪些？
  • 日本醫療低溫運輸物流市場競爭程度如何？

目錄

第1章：序言

第2章：調查範圍與調查方法

  • 調查目標
  • 相關利益者
  • 數據來源
  • 市場估值
  • 調查方法

第3章執行摘要

第4章：日本醫療低溫運輸物流市場概況

  • 概述
  • 市場動態
  • 產業趨勢
  • 競爭資訊

第5章：日本醫療低溫運輸物流市場概況

  • 過去和當前的市場趨勢（2020-2025）
  • 市場預測（2026-2034）

第6章：日本醫療低溫運輸物流市場：依產品細分

  • 臨床試驗材料
  • 疫苗
  • 生物製藥

第7章：日本醫療低溫運輸物流市場－按細分市場分析

  • 運輸
  • 包裝
  • 測量設備

第8章：日本醫療低溫運輸物流市場：依地區分類

  • 關東地區
  • 關西、近畿地區
  • 中部地區
  • 九州和沖繩地區
  • 東北部地區
  • 中國地區
  • 北海道地區
  • 四國地區

第9章：日本醫療低溫運輸物流市場：競爭格局

  • 概述
  • 市場結構
  • 市場公司定位
  • 關鍵成功策略
  • 競爭對手儀錶板
  • 企業估值象限

第10章主要企業概況

第11章：日本醫療低溫運輸物流市場：產業分析

  • 促進因素、限制因素和機遇
  • 波特五力分析
  • 價值鏈分析

第12章附錄

簡介目錄
Product Code: SR112026A33321

The Japan healthcare cold chain logistics market size reached USD 1,104.2 Million in 2025 . Looking forward, IMARC Group expects the market to reach USD 1,501.0 Million by 2034 , exhibiting a growth rate (CAGR) of 3.47% during 2026-2034 . The market is driven by the growing demand for temperature-sensitive biopharmaceutical products, improvements in cold storage infrastructure, and the rising need to meet stringent regulatory standards. Additionally, the expanding distribution of vaccines and biologics and the integration of advanced technologies such as the Internet of Things (IoT) and radio frequency identification (RFID) for real-time tracking are also contributing significantly to the market growth.

JAPAN HEALTHCARE COLD CHAIN LOGISTICS MARKET TRENDS:

Expansion of Biopharmaceuticals and Personalized Therapies

Japan's healthcare cold chain logistics sector is experiencing robust growth, driven by the rising demand for biopharmaceuticals and personalized medical treatments. Biologics, such as monoclonal antibodies and mRNA vaccines, require stringent temperature control to preserve their efficacy. As of 2024, major logistics companies like Nippon Express and Kintetsu World Express have increased their cold chain capacity for biopharmaceuticals from 18% in 2020 to 30%. The aging population in Japan, with over 30% of residents aged 65 and above, is further propelling the demand for advanced therapies. Additionally, the Japanese government's initiatives, including the 2024 Life Sciences Roadmap and a JPY 2 trillion investment in healthcare digitization, are enhancing domestic biomanufacturing and personalized medicine efforts. According to the Japan Ministry of Health, Labor and Welfare, global biopharmaceutical sales represented over 38% of Japan's total pharmaceutical market in 2023, highlighting the growing need for reliable cold chain logistics to support the distribution of temperature-sensitive medical products.

To get more information on this market Request Sample

Technological Advancements in Cold Chain Logistics

Technological advancements are transforming Japan's healthcare cold chain logistics by enhancing operational efficiency and safeguarding the quality of temperature-sensitive medical products. The integration of Internet of Things (IoT) devices enables real-time monitoring of temperature and humidity during transportation and storage, enhancing operational efficiency. Blockchain technology is also gaining traction for its ability to provide transparent, tamper-proof records, ensuring compliance with strict regulatory standards and boosting stakeholder trust. For example, as of April 2025, 62% of hospitals in Japan now mandate real-time temperature tracking for biologics, up from 45% in 2021. Additionally, artificial intelligence (AI) and predictive analytics are being utilized to forecast potential disruptions in the supply chain, enabling proactive risk mitigation. These advancements are essential in maintaining the efficacy of sensitive healthcare products and are fueling the growth of Japan's cold chain logistics market.

JAPAN HEALTHCARE COLD CHAIN LOGISTICS MARKET SEGMENTATION:

Product Insights:

  • Clinical Trial Materials
  • Vaccines
  • Biopharmaceuticals
  • Clinical Trial Materials
  • Vaccines
  • Biopharmaceuticals

Segment Insights:

  • Access the comprehensive market breakdown Request Sample
  • Transportation
  • Packaging
  • Instrumentation
  • Transportation
  • Packaging
  • Instrumentation

Regional Insights:

  • Kanto Region
  • Kansai/Kinki Region
  • Central/ Chubu Region
  • Kyushu-Okinawa Region
  • Tohoku Region
  • Chugoku Region
  • Hokkaido Region
  • Shikoku Region
  • Kanto Region
  • Kansai/Kinki Region
  • Central/ Chubu Region
  • Kyushu-Okinawa Region
  • Tohoku Region
  • Chugoku Region
  • Hokkaido Region
  • Shikoku Region
  • The report has also provided a comprehensive analysis of all the major regional markets, which include Kanto Region, Kansai/Kinki Region, Central/ Chubu Region, Kyushu-Okinawa Region, Tohoku Region, Chugoku Region, Hokkaido Region, and Shikoku Region.

COMPETITIVE LANDSCAPE:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

  • KEY QUESTIONS ANSWERED IN THIS REPORT
  • How has the Japan healthcare cold chain logistics market performed so far and how will it perform in the coming years?
  • What is the breakup of the Japan healthcare cold chain logistics market on the basis of product?
  • What is the breakup of the Japan healthcare cold chain logistics market on the basis of segment?
  • What are the various stages in the value chain of the Japan healthcare cold chain logistics market?
  • What are the key driving factors and challenges in the Japan healthcare cold chain logistics?
  • What is the structure of the Japan healthcare cold chain logistics market and who are the key players?
  • What is the degree of competition in the Japan healthcare cold chain logistics market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Japan Healthcare Cold Chain Logistics Market - Introduction

  • 4.1 Overview
  • 4.2 Market Dynamics
  • 4.3 Industry Trends
  • 4.4 Competitive Intelligence

5 Japan Healthcare Cold Chain Logistics Market Landscape

  • 5.1 Historical and Current Market Trends (2020-2025)
  • 5.2 Market Forecast (2026-2034)

6 Japan Healthcare Cold Chain Logistics Market - Breakup by Product

  • 6.1 Clinical Trial Materials
    • 6.1.1 Overview
    • 6.1.2 Historical and Current Market Trends (2020-2025)
    • 6.1.3 Market Forecast (2026-2034)
  • 6.2 Vaccines
    • 6.2.1 Overview
    • 6.2.2 Historical and Current Market Trends (2020-2025)
    • 6.2.3 Market Forecast (2026-2034)
  • 6.3 Biopharmaceuticals
    • 6.3.1 Overview
    • 6.3.2 Historical and Current Market Trends (2020-2025)
    • 6.3.3 Market Forecast (2026-2034)

7 Japan Healthcare Cold Chain Logistics Market - Breakup by Segment

  • 7.1 Transportation
    • 7.1.1 Overview
    • 7.1.2 Historical and Current Market Trends (2020-2025)
    • 7.1.3 Market Forecast (2026-2034)
  • 7.2 Packaging
    • 7.2.1 Overview
    • 7.2.2 Historical and Current Market Trends (2020-2025)
    • 7.2.3 Market Forecast (2026-2034)
  • 7.3 Instrumentation
    • 7.3.1 Overview
    • 7.3.2 Historical and Current Market Trends (2020-2025)
    • 7.3.3 Market Forecast (2026-2034)

8 Japan Healthcare Cold Chain Logistics Market - Breakup by Region

  • 8.1 Kanto Region
    • 8.1.1 Overview
    • 8.1.2 Historical and Current Market Trends (2020-2025)
    • 8.1.3 Market Breakup by Product
    • 8.1.4 Market Breakup by Segment
    • 8.1.5 Key Players
    • 8.1.6 Market Forecast (2026-2034)
  • 8.2 Kansai/Kinki Region
    • 8.2.1 Overview
    • 8.2.2 Historical and Current Market Trends (2020-2025)
    • 8.2.3 Market Breakup by Product
    • 8.2.4 Market Breakup by Segment
    • 8.2.5 Key Players
    • 8.2.6 Market Forecast (2026-2034)
  • 8.3 Central/ Chubu Region
    • 8.3.1 Overview
    • 8.3.2 Historical and Current Market Trends (2020-2025)
    • 8.3.3 Market Breakup by Product
    • 8.3.4 Market Breakup by Segment
    • 8.3.5 Key Players
    • 8.3.6 Market Forecast (2026-2034)
  • 8.4 Kyushu-Okinawa Region
    • 8.4.1 Overview
    • 8.4.2 Historical and Current Market Trends (2020-2025)
    • 8.4.3 Market Breakup by Product
    • 8.4.4 Market Breakup by Segment
    • 8.4.5 Key Players
    • 8.4.6 Market Forecast (2026-2034)
  • 8.5 Tohoku Region
    • 8.5.1 Overview
    • 8.5.2 Historical and Current Market Trends (2020-2025)
    • 8.5.3 Market Breakup by Product
    • 8.5.4 Market Breakup by Segment
    • 8.5.5 Key Players
    • 8.5.6 Market Forecast (2026-2034)
  • 8.6 Chugoku Region
    • 8.6.1 Overview
    • 8.6.2 Historical and Current Market Trends (2020-2025)
    • 8.6.3 Market Breakup by Product
    • 8.6.4 Market Breakup by Segment
    • 8.6.5 Key Players
    • 8.6.6 Market Forecast (2026-2034)
  • 8.7 Hokkaido Region
    • 8.7.1 Overview
    • 8.7.2 Historical and Current Market Trends (2020-2025)
    • 8.7.3 Market Breakup by Product
    • 8.7.4 Market Breakup by Segment
    • 8.7.5 Key Players
    • 8.7.6 Market Forecast (2026-2034)
  • 8.8 Shikoku Region
    • 8.8.1 Overview
    • 8.8.2 Historical and Current Market Trends (2020-2025)
    • 8.8.3 Market Breakup by Product
    • 8.8.4 Market Breakup by Segment
    • 8.8.5 Key Players
    • 8.8.6 Market Forecast (2026-2034)

9 Japan Healthcare Cold Chain Logistics Market - Competitive Landscape

  • 9.1 Overview
  • 9.2 Market Structure
  • 9.3 Market Player Positioning
  • 9.4 Top Winning Strategies
  • 9.5 Competitive Dashboard
  • 9.6 Company Evaluation Quadrant

10 Profiles of Key Players

  • 10.1 Company A
    • 10.1.1 Business Overview
    • 10.1.2 Services Offered
    • 10.1.3 Business Strategies
    • 10.1.4 SWOT Analysis
    • 10.1.5 Major News and Events
  • 10.2 Company B
    • 10.2.1 Business Overview
    • 10.2.2 Services Offered
    • 10.2.3 Business Strategies
    • 10.2.4 SWOT Analysis
    • 10.2.5 Major News and Events
  • 10.3 Company C
    • 10.3.1 Business Overview
    • 10.3.2 Services Offered
    • 10.3.3 Business Strategies
    • 10.3.4 SWOT Analysis
    • 10.3.5 Major News and Events
  • 10.4 Company D
    • 10.4.1 Business Overview
    • 10.4.2 Services Offered
    • 10.4.3 Business Strategies
    • 10.4.4 SWOT Analysis
    • 10.4.5 Major News and Events
  • 10.5 Company E
    • 10.5.1 Business Overview
    • 10.5.2 Services Offered
    • 10.5.3 Business Strategies
    • 10.5.4 SWOT Analysis
    • 10.5.5 Major News and Events

11 Japan Healthcare Cold Chain Logistics Market - Industry Analysis

  • 11.1 Drivers, Restraints, and Opportunities
    • 11.1.1 Overview
    • 11.1.2 Drivers
    • 11.1.3 Restraints
    • 11.1.4 Opportunities
  • 11.2 Porters Five Forces Analysis
    • 11.2.1 Overview
    • 11.2.2 Bargaining Power of Buyers
    • 11.2.3 Bargaining Power of Suppliers
    • 11.2.4 Degree of Competition
    • 11.2.5 Threat of New Entrants
    • 11.2.6 Threat of Substitutes
  • 11.3 Value Chain Analysis

12 Appendix